Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations
What Is the Forecasted Market Size of the Bioactive Wound Care Market by 2029?
The bioactive wound care market size has grown strongly in recent years. It will grow from $7.60 billion in 2024 to $8.28 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing prevalence of chronic wounds, rising diabetic population, growing aging population, increasing surgical wound cases, and rising awareness among healthcare professionals.
The bioactive wound care market size is expected to see strong growth in the next few years. It will grow to $11.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing prevalence of chronic diseases, increasing demand for advanced wound care, rising adoption of bioactive dressings, growing geriatric population, and increasing healthcare expenditure. Major trends in the forecast period include advancements in antimicrobial dressings, integration of smart dressings, technology in wound monitoring, developments in growth factor applications, and advancements in hydrogel dressings.
Claim your free report sample now:
Which Factors Are Driving Growth in the Bioactive Wound Care Market?
The increasing number of trauma cases is expected to propel the growth of the bioactive wound care market going forward. Trauma cases refer to instances of physical injury resulting from external forces such as accidents, falls, or violence, often requiring urgent medical intervention. The increase in trauma cases is largely driven by the rising number of road traffic accidents due to growing vehicle usage and inadequate road safety measures. Bioactive wound care helps in trauma cases by promoting faster healing, preventing infections, and supporting tissue regeneration in complex or severe wounds. For instance, in December 2024, the Transport Accident Commission, an Australia-based government agency, reported that there were 267 fatal crashes on Victorian roads in the 12 months to the end of June 2024, marking an increase of 20 compared to the 247 fatal crashes recorded during the previous year. Therefore, the increasing number of trauma cases is driving the growth of the bioactive wound care market.
What Are the Key Segments in the Bioactive Wound Care Market?
The bioactive wound care market covered in this report is segmented
1) By Product Type: Antimicrobial Dressings, Hydrogels, Alginates, Foams, Collagen Dressings, Silver-Based Dressings, Hydrofiber Dressings
2) By Mode Of Action: Antibacterial Action, Anti-Inflammatory Action, Wound Healing Promotion, Moisture Control
3) By Application: Chronic Wounds, Acute Wounds, Burns, Surgical Wounds, Diabetic Foot Ulcers, Pressure Ulcers
4) By End User: Hospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers, Nursing Homes
Subsegments:
1) By Antimicrobial Dressings: Silver-Impregnated Dressings, Iodine-Based Dressings, Honey-Based Dressings
2) By Hydrogels: Amorphous Hydrogel, Hydrogel Sheets, Hydrogel Impregnated Gauze
3) By Alginates: Calcium Alginate Dressings, Calcium Sodium Alginate Dressings
4) By Foams: Silicone Foam Dressings, Polyurethane Foam Dressings, Adhesive And Non-Adhesive Foams
5) By Collagen Dressings: Bovine Collagen, Porcine Collagen, Synthetic Collagen
6) By Silver-Based Dressings: Nanocrystalline Silver Dressings, Silver Sulfadiazine Dressings
7) By Hydrofiber Dressings: Adhesive Hydrofiber, Non-Adhesive Hydrofiber
What Are the Emerging Market Trends That Companies Should Monitor in Bioactive Wound Care Market?
Major companies operating in the bioactive wound care market are focusing on developing innovative solutions, such as antimicrobial wound dressings, to enhance infection control, accelerate healing processes, and reduce the risk of complications in chronic and acute wounds. Antimicrobial wound dressing refers to a type of wound care product infused with antimicrobial agents such as silver, iodine, or honey, designed to prevent or reduce microbial contamination, control infection, and promote faster wound healing. For instance, in October 2024, Imbed Biosciences Inc., a US-based medical device company, received FDA 510(k) clearance for Microlyte Ag, or lidocaine, the first antimicrobial wound dressing that integrates lidocaine to manage painful skin wounds. It is a wound dressing that combines antimicrobial silver and lidocaine to both prevent infection and provide local pain relief in various partial- and full-thickness wounds. It promotes healing by maintaining a moist environment and reducing pain, potentially lowering the need for systemic antibiotics and opioids.
Who Are the Leading Players in the Bioactive Wound Care Market?
Major companies operating in the bioactive wound care market are 3M Company, Smith & Nephew PLC, Coloplast A/S, PAUL HARTMANN AG, Mölnlycke Health Care AB, CONVATEC GROUP PLC., Hollister Incorporated, Organogenesis Holdings Inc., DeRoyal Industries Inc., MiMedx Group Inc., B. Braun SE, Kerecis Inc., Sanara MedTech Inc., Aroa Biosurgery Limited, BioMonde GmbH, DermaRite Industries LLC., BSN MEDICAL PRIVATE LIMITED, Covalon Technologies Ltd., Sonoma Pharmaceuticals Inc., and Integra LifeSciences Holdings Corporation.
Get the full bioactive wound care market report here:
What Are the Key Regional Trends in the Bioactive Wound Care Market?
North America was the largest region in the bioactive wound care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioactive wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment